Mean Ankylosing Spondylitis Disease Activity Score with C‐reactive
Por um escritor misterioso
Descrição
OP0080 CENTRAL SENSITIZATION AND ILLNESS PERCEPTIONS SHOULD BE
Non-inferiority of dose reduction versus standard dosing of TNF
Frontiers Higher Levels of Secretory IgA Are Associated with Low
Low BASDAI score alone is not a good predictor of anti-tumor
Baseline Characteristics of Patients with Ankylosing Spondylitis
Etanercept in the treatment of ankylosing spondylitis: A
Early control of C‐reactive protein levels with non‐biologics is
Correlation between serum secretory immunoglobulin A (S
Treat to target in axial spondyloarthritis: From its concept to
Secukinumab in non-radiographic axial spondyloarthritis: subgroup
Abbreviations: BASDAI, Bath Ankylosing Spondylitis Disease
Fecal calprotectin is associated with disease activity in patients
ASDAS calculator - ASAS
Demographic, clinical, and laboratory features of Turkish patients
de
por adulto (o preço varia de acordo com o tamanho do grupo)
